Related Experiment Videos
UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation
K Shibata1, M Kashiwada, M Ueki
1Faculty of Science, Osaka City University, Japan.
The Journal of Antibiotics
|July 1, 1993
Abstract:
The structure of UK-1 isolated from the mycelium of Streptomyces sp. 517-02 was elucidated to be a novel benzoxazole dimmer derivative (1) on the basis of spectroscopic methods.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene.
The Journal of biological chemistry·1992
Hemichorea associated with ipsilateral chronic subdural hematoma--case report.
Neurologia medico-chirurgica·1992
[A case of endoscopic laser polypectomy for endobronchial hamartoma].
Nihon Kyobu Shikkan Gakkai zasshi·1992
Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid.
Journal of the American Academy of Dermatology·1992
[A case report of solitary bone cyst of rib detected from pathological fracture].
Kyobu geka. The Japanese journal of thoracic surgery·1992
"Lariocidin and ribosome-targeting lasso peptides as emerging antimicrobial agents against multidrug-resistant bacteria".
The Journal of antibiotics·2026
Two new diastereomeric sterigmatocystin derivatives from the culture broth of Hypomyces sp.
The Journal of antibiotics·2026
Methods of predicting clinically significant DRUG-DRUG interactions beyond validated interaction checkers.
Expert opinion on drug metabolism & toxicology·2026
Cholinesterase Inhibitors in Alzheimer's Disease: Medicinal Chemistry, Mechanistic Insights, and Emerging Multitarget Strategies.
CNS & neurological disorders drug targets·2026
Discovery of a Caffeic Acid Thioamide with Potent Activity against Pathogenic Fungi and Fluconazole Tolerance-Eliminating Effects in Candida albicans.
Drug design, development and therapy·2026